Author:
Zulu Gideon,Stelzle Dominik,Gabriël Sarah,Trevisan Chiara,Van Damme Inge,Mubanga Chishimba,Schmidt Veronika,Ngowi Bernard J.,Welte Tamara M.,Magnussen Pascal,Ruether Charlotte,Fleury Agnes,Dorny Pierre,Bottieau Emmanuel,Phiri Isaac K.,Mwape Kabemba E.,Winkler Andrea S.,
Abstract
Abstract
Background
This study aimed at describing the epidemiology of (neuro)cysticercosis as well as its clinical and radiological characteristics in a Taenia solium endemic district of Zambia.
Methods
This was part of a cross-sectional community-based study conducted in Sinda district to evaluate an antibody-detecting T. solium point-of-care (TS POC) test for taeniosis and (neuro)cysticercosis. All TS POC cysticercosis positive (CC+) participants and a subset of the TS POC cysticercosis negative (CC-) received a clinical evaluation and cerebral computed tomography (CT) examination for neurocysticercosis (NCC) diagnosis and staging.
Results
Of the 1249 participants with a valid TS POC test result, 177 (14%) were TS POC CC+ . Cysticercosis sero-prevalence was estimated to be 20.1% (95% confidence intervals [CI] 14.6–27.0%). In total, 233 participants received a CT examination (151 TS POC CC+ , 82 TS POC CC-). Typical NCC lesions were present in 35/151 (23%) TS POC CC+ , and in 10/82 (12%) TS POC CC- participants. NCC prevalence was 13.5% (95% CI 8.4–21.1%) in the study population and 38.0% (95% CI 5.2–87.4%) among people reporting epileptic seizures. Participants with NCC were more likely to experience epileptic seizures (OR = 3.98, 95% CI 1.34–11.78, p = 0.01) than those without NCC, although only 7/45 (16%) people with NCC ever experienced epileptic seizures. The number of lesions did not differ by TS POC CC status (median: 3 [IQR 1–6] versus 2.5 [IQR 1–5.3], p = 0.64). Eight (23%) of the 35 TS POC CC+ participants with NCC had active stage lesions; in contrast none of the TS POC CC- participants was diagnosed with active NCC.
Conclusion
NCC is common in communities in the Eastern province of Zambia, but a large proportion of people remain asymptomatic.
Funder
European and Developing Countries Clinical Trials Partnership
German Federal Ministry of Education and Research
Publisher
Springer Science and Business Media LLC